0001104659-20-122032.txt : 20201105
0001104659-20-122032.hdr.sgml : 20201105
20201105201448
ACCESSION NUMBER: 0001104659-20-122032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201103
FILED AS OF DATE: 20201105
DATE AS OF CHANGE: 20201105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lefenfeld Michael
CENTRAL INDEX KEY: 0001826906
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39580
FILM NUMBER: 201292114
MAIL ADDRESS:
STREET 1: IMMUNOME, INC.
STREET 2: 665 STOCKTON DRIVE, SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunome Inc.
CENTRAL INDEX KEY: 0001472012
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770694340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 610-321-3700
MAIL ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
a4.xml
4
X0306
4
2020-11-03
0
0001472012
Immunome Inc.
IMNM
0001826906
Lefenfeld Michael
C/O IMMUNOME, INC.
665 STOCKTON DRIVE, SUITE 300
EXTON
PA
19341
1
0
0
0
Stock Option (Right to Buy)
11.38
2020-11-03
4
A
0
7500
0
A
2030-11-03
Common Stock
7500
7500
D
One-twelfth (1/12th) of the shares subject to the option shall vest on February 3, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest every three months thereafter.
/s/ Richard F. Fitzgerald, Attorney-in-Fact
2020-11-05